Heterogeneity in sepsis: new biological evidence with clinical applications

Aleksandra Leligdowicz; Michael A Matthay

doi:10.1186/s13054-019-2372-2

Heterogeneity in sepsis: new biological evidence with clinical applications

Crit Care. 2019 Mar 9;23(1):80. doi: 10.1186/s13054-019-2372-2.

Authors

Aleksandra Leligdowicz^{1

2}, Michael A Matthay^{3

4

5}

Affiliations

¹ Cardiovascular Research Institute, University of California-San Francisco, San Francisco, CA, USA. aleksandra.leligdowicz@uhn.ca.
² Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada. aleksandra.leligdowicz@uhn.ca.
³ Cardiovascular Research Institute, University of California-San Francisco, San Francisco, CA, USA.
⁴ Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, University of California-San Francisco, San Francisco, CA, USA.
⁵ Departments of Medicine and Anesthesia, University of California-San Francisco, San Francisco, CA, USA.

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2019. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2019 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from http://www.springer.com/series/8901 .

Publication types

Review

MeSH terms

Critical Care / trends
Humans
Intensive Care Units / organization & administration
Sepsis / classification*
Sepsis / physiopathology*

Grants and funding

R01 HL134828/HL/NHLBI NIH HHS/United States